In Australia each year, about 1,600 women are diagnosed with ovarian cancer and 1,000 die from this disease. Research at the Royal Adelaide Hospital is focussed on early detection and more effective treatments to improve survival. Read more
The Urology Unit is transitioning traditional surgery to modern, minimally invasive robotic surgery, with many benefits for patients. Read more
The Department of Gastroenterology and Hepatology is undertaking pioneering work in treatments for chronic sufferers of Inflammatory Bowel Disease (IBD). Read more
The Hepatology Unit at the RAH is conducting pioneering medical research and developing cutting edge technology to combat deadly chronic liver diseases. Read more
Colorectal cancer is estimated to become the second most commonly diagnosed cancer in Australia by the end of this year. The RAH researchers are improving the rate of recovery and quality of life after surgery. Read more
Chronic lung disease is the third leading cause of death world-wide. World-leading research at the RAH is helping patients to breathe easier. Read more
The team at the Centre are developing possibly one of the world’s first targeted treatments for Acute Myeloid Leukaemia – the cancer that tragically cut short the life of golfer Jarrod Lyle. Read more
Ovarian cancer is a devastating disease that has been dubbed the “silent killer”. Dr Pitman’s team is focused on developing more weapons in the treatment arsenal and improving patient outcomes. Read more
The Rheumatology Unit is taking a “bench to bedside” approach to research with an emphasis on treating chronic auto-immune diseases such as crippling Rheumatoid Arthritis and gaining an international reputation. Read more
Pioneering studies into the relevance of stomach and intestine functions to diabetes, appetite regulation, ageing and critical illness by Professor Horowitz has led to fundamental changes in strategies for patient management. Read more